Roper Technologies (RHHBY.US) is reportedly planning to spin off Flatiron Health, a healthcare data technology company it bought for $1.9 billion six years ago.
AInvestWednesday, Aug 7, 2024 3:20 am ET
1min read
C --
TOI --

According to media reports citing sources, Swiss pharmaceutical giant Roche (RHHBY.US) is considering to spin off its medical data technology company Flatiron Health. It is reported that Roche is currently working with Citigroup (C.US) to evaluate options for Flatiron Health, including spinning off the business or selling part of the business to a partner that may help run the business.

Roche spent $1.9 billion to acquire Flatiron Health in 2018 to accelerate the development of its oncology drugs and support its pricing of drugs based on efficacy. Flatiron Health is an electronic health record software provider focused on oncology. The company collects clinical records, medical notes, genetic information, medical cost information, genomic data from multiple sources, and presents them to oncologists or helps doctors make better clinical diagnoses through integration. The company has also been supported by Alphabet (GOOGL.US).

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.